we purchased all of the assets of Link associated with CT-95, including patent rights, know-how, regulatory filings, and inventory of drug substance and drug product
Context Therapeutics Inc. Customers
No clients on recordNo downstream customers found in our database for Context Therapeutics Inc..
Context Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CNTX-DEBT
Debt stack $282,424
90%
Market cache reports total debt of $282,424.
CNTX-DEBT-8758
Warrants outstanding: 345530
90%
xbrl warrant detail from xbrl 2022-12-31.
CNTX-DEBT-8759
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
Context Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Context Therapeutics Inc..
Context Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
CNTX-OWNER-MPM-BIOIMPACT-LLC
MPM BIOIMPACT LLC
90%
13F overlay lists MPM BIOIMPACT LLC as top holder; 61 tracked holders.
Context Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.